๐ก Get more than just numbers. Subscribe to access AI-powered analysis of company reports โ key trends and metrics in a simple, easy-to-understand format.
Estimate
P/E
27.4
EPS
5.41
Beta
1.095
Growth
Revenue, YoY
23.51%
Net income, YoY
322.22%
FCF, YoY
-16.1%
Forecast
P/E (FWD)
19.2
EPS (FWD)
7.734
About the company
Ticker
PODD
ISIN
US45784P1012
Country
United States of America
Sector (GICS)
Healthcare
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Frequently asked questions
What sector does Insulet Corporation (PODD) operate in?
Insulet Corporation belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Insulet Corporation (PODD) current stock price?
As of the latest data, Insulet Corporation stock price is $148.16, with a previous close of $146.87. Insulet Corporation gained $1.29 in the last trading session, representing a 0.88% increase.
What is Insulet Corporation (PODD) current market capitalization?
Insulet Corporation market cap is approximately 10.28 billion.
What is Insulet Corporation (PODD) Earnings Per Share (EPS)?
The trailing EPS is $5.41, and the forward EPS is $7.73.
What is Insulet Corporation (PODD) Price-to-Earnings (P/E) ratio?
Insulet Corporation current P/E ratio is 27.39, with a forward P/E of 19.16.
What is Insulet Corporation (PODD) EBITDA?
Insulet Corporation EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 132.20 million.
Does Insulet Corporation (PODD) pay dividends?
No. Insulet Corporation does not pay a dividend.
How did Insulet Corporation (PODD) perform in its most recent earnings report?
In the last report (June 30, 2026), Insulet Corporation posted an EPS surprise of 15.28% and a revenue surprise of 1.81%.
What is Insulet Corporation (PODD) beta (volatility) score?
Insulet Corporation has a beta of 1.095, meaning its volatility is roughly in line with the market.
